Cost impact of switching histamine(2)-receptor antagonists to nonprescription status. (Record no. 11980984)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01190 a2200337 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250514035240.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200211s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1060-0280 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1345/aph.1A231 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Furler, Michelle D |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20021126 |
| 245 00 - TITLE STATEMENT | |
| Title | Cost impact of switching histamine(2)-receptor antagonists to nonprescription status. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Annals of pharmacotherapy |
| Date of publication, distribution, etc. | |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1135-41 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Canada |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gastrointestinal Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Histamine H2 Antagonists |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nonprescription Drugs |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pharmacoepidemiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United Kingdom |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | United States |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rolnick, Mark S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lawday, Kathleen S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mak, Miranda W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Einarson, Thomas R |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Annals of pharmacotherapy |
| Related parts | vol. 36 |
| -- | no. 7-8 |
| -- | p. 1135-41 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1345/aph.1A231">https://doi.org/10.1345/aph.1A231</a> |
| Public note | Available from publisher's website |
No items available.